Report Detail

Other Global Tuberculosis Diagnostics Market Size, Status and Forecast 2019-2025

  • RnM3059751
  • |
  • 05 March, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The classification of Tuberculosis diagnostics includes culture-based diagnostics, sputum smear microscopy diagnostics, rapid molecular diagnostics and so on. And the proportion of Culture-based Diagnostic in 2017 is about 34.84%, and the proportion is in decreasing trend from 2013 to 2017.
Tuberculosis Diagnostics is widely used in hospital, diagnostic laboratories and other field. The most proportion of Tuberculosis Diagnostics is hospital, and the revenue in 2017 is 542 M USD.
Europe is the largest consumption place, with a Revenue market share nearly 42.03% in 2017. Following Europe, Africa is the second largest consumption place with the Revenue market share of 35.76%.
In 2018, the global Tuberculosis Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Tuberculosis Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tuberculosis Diagnostics development in United States, Europe and China.

The key players covered in this study
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Epistem
Akonni Biosystems
Creative Diagnostics

Market segment by Type, the product can be split into
Culture-based
Sputum Smear Microscopy
Rapid Molecular
Others

Market segment by Application, split into
Hospital
Diagnostic Laboratories
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tuberculosis Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Tuberculosis Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Tuberculosis Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Tuberculosis Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Culture-based
      • 1.4.3 Sputum Smear Microscopy
      • 1.4.4 Rapid Molecular
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Tuberculosis Diagnostics Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Diagnostic Laboratories
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Tuberculosis Diagnostics Market Size
    • 2.2 Tuberculosis Diagnostics Growth Trends by Regions
      • 2.2.1 Tuberculosis Diagnostics Market Size by Regions (2014-2025)
      • 2.2.2 Tuberculosis Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Tuberculosis Diagnostics Market Size by Manufacturers
      • 3.1.1 Global Tuberculosis Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Tuberculosis Diagnostics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Tuberculosis Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Tuberculosis Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Tuberculosis Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Tuberculosis Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Tuberculosis Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Tuberculosis Diagnostics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Tuberculosis Diagnostics Market Size (2014-2019)
    • 5.2 Tuberculosis Diagnostics Key Players in United States
    • 5.3 United States Tuberculosis Diagnostics Market Size by Type
    • 5.4 United States Tuberculosis Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Tuberculosis Diagnostics Market Size (2014-2019)
    • 6.2 Tuberculosis Diagnostics Key Players in Europe
    • 6.3 Europe Tuberculosis Diagnostics Market Size by Type
    • 6.4 Europe Tuberculosis Diagnostics Market Size by Application

    7 China

    • 7.1 China Tuberculosis Diagnostics Market Size (2014-2019)
    • 7.2 Tuberculosis Diagnostics Key Players in China
    • 7.3 China Tuberculosis Diagnostics Market Size by Type
    • 7.4 China Tuberculosis Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Tuberculosis Diagnostics Market Size (2014-2019)
    • 8.2 Tuberculosis Diagnostics Key Players in Japan
    • 8.3 Japan Tuberculosis Diagnostics Market Size by Type
    • 8.4 Japan Tuberculosis Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Tuberculosis Diagnostics Market Size (2014-2019)
    • 9.2 Tuberculosis Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Tuberculosis Diagnostics Market Size by Type
    • 9.4 Southeast Asia Tuberculosis Diagnostics Market Size by Application

    10 India

    • 10.1 India Tuberculosis Diagnostics Market Size (2014-2019)
    • 10.2 Tuberculosis Diagnostics Key Players in India
    • 10.3 India Tuberculosis Diagnostics Market Size by Type
    • 10.4 India Tuberculosis Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Tuberculosis Diagnostics Market Size (2014-2019)
    • 11.2 Tuberculosis Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Tuberculosis Diagnostics Market Size by Type
    • 11.4 Central & South America Tuberculosis Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Danaher
      • 12.1.1 Danaher Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Tuberculosis Diagnostics Introduction
      • 12.1.4 Danaher Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.1.5 Danaher Recent Development
    • 12.2 Roche
      • 12.2.1 Roche Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Tuberculosis Diagnostics Introduction
      • 12.2.4 Roche Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.2.5 Roche Recent Development
    • 12.3 Thermo Fisher Scientific
      • 12.3.1 Thermo Fisher Scientific Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Tuberculosis Diagnostics Introduction
      • 12.3.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.3.5 Thermo Fisher Scientific Recent Development
    • 12.4 BD
      • 12.4.1 BD Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Tuberculosis Diagnostics Introduction
      • 12.4.4 BD Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.4.5 BD Recent Development
    • 12.5 Abbott
      • 12.5.1 Abbott Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Tuberculosis Diagnostics Introduction
      • 12.5.4 Abbott Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.5.5 Abbott Recent Development
    • 12.6 Hologic
      • 12.6.1 Hologic Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Tuberculosis Diagnostics Introduction
      • 12.6.4 Hologic Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.6.5 Hologic Recent Development
    • 12.7 Qiagen
      • 12.7.1 Qiagen Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Tuberculosis Diagnostics Introduction
      • 12.7.4 Qiagen Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.7.5 Qiagen Recent Development
    • 12.8 BioMerieux
      • 12.8.1 BioMerieux Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Tuberculosis Diagnostics Introduction
      • 12.8.4 BioMerieux Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.8.5 BioMerieux Recent Development
    • 12.9 Hain Lifescience
      • 12.9.1 Hain Lifescience Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Tuberculosis Diagnostics Introduction
      • 12.9.4 Hain Lifescience Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.9.5 Hain Lifescience Recent Development
    • 12.10 Oxford Immunotec
      • 12.10.1 Oxford Immunotec Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Tuberculosis Diagnostics Introduction
      • 12.10.4 Oxford Immunotec Revenue in Tuberculosis Diagnostics Business (2014-2019)
      • 12.10.5 Oxford Immunotec Recent Development
    • 12.11 Epistem
    • 12.12 Akonni Biosystems
    • 12.13 Creative Diagnostics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Tuberculosis Diagnostics . Industry analysis & Market Report on Tuberculosis Diagnostics is a syndicated market report, published as Global Tuberculosis Diagnostics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Tuberculosis Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,120.00
      4,680.00
      6,240.00
      3,642.60
      5,463.90
      7,285.20
      613,587.00
      920,380.50
      1,227,174.00
      325,221.00
      487,831.50
      650,442.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report